Keywords: زمان به حداکثر غلظت پلاسما; COPD; Budesonide; Formoterol fumarate dihydrate; Glycopyrronium; Co-suspension delivery technology; Pharmacokinetic; AE; adverse event; AUC0-â; area under the plasma concentration-time curve from time 0 to infinity; AUC0-12; area under the plasma
مقالات ISI زمان به حداکثر غلظت پلاسما (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: زمان به حداکثر غلظت پلاسما; Beclometasone; Formoterol; Children; Adolescents; Adults; Asthma; AUC; area under the plasma drug concentration-time curve; BDP; beclometasone-dipropionate; B17MP; beclometasone-17-monopropionate; Cmax; maximum plasma concentration; FEV1; forced expirator
In Vitro-In Vivo Evaluation of an Oral Ghost Drug Delivery Device for the Delivery of Salmon Calcitonin
Keywords: زمان به حداکثر غلظت پلاسما; oral absorption; peptide delivery; pharamcokinetics; proteins; drug transport; polymer synthesis; OGDD; Oral Ghost Drug Delivery; UHMW-PE; ultra-high-molecular-weight polyethylene; AAm; polyethylene: acrylamide monomers; MAA; methyacrylic acid; BIS; N-N
Defining level A IVIVC dissolution specifications based on individual in vitro dissolution profiles of a controlled release formulation
Keywords: زمان به حداکثر غلظت پلاسما; AUC; area under the curve; BE; bioequivalence; CI; confidence interval; CL; clearance; Cmax; maximum plasma concentration; CR; controlled release; CV; coefficient of variation; f2; similarity factor; FTFF; the fastest tablet of the fastest dissolving form
Nucleosidic DNA demethylating epigenetic drugs - A comprehensive review from discovery to clinic
Keywords: زمان به حداکثر غلظت پلاسما; ALL; Acute lymphoblastic leukemia; AML; Acute myeloid leukemia; AUC; Area under the curve; AZA; 5-azacytidine; 5-aza-CdR; 2â²-deoxy-5-azacytidine; 5-aza-CR; 5-azacytidine; AZN; Azanucleosides; BED; Biologically effective dose; BSC; Best supportive care;
A rapid and sensitive UHPLC-MS/MS method for quantification of 83b1 in plasma and its application to bioavailability study in rats
Keywords: زمان به حداکثر غلظت پلاسما; UHPLC-MS/MS; ultra-high performance liquid chromatography tandem mass spectrometry; ESCC; esophageal squamous cell carcinoma; PPAR; peroxisome proliferator-activated receptor; CDDP; cisplatin; COX-2; cyclooxygenase-2; PGH; prostaglandin H; MTS; 3-(4,5-d
A PEGylated analog of short-length Neuromedin U with potent anorectic and anti-obesity effects
Keywords: زمان به حداکثر غلظت پلاسما; Neuromedin U (NMU); NMU-8; Polyethylene glycol (PEG); Diabetes; Obesity; NMU; neuromedin U; PEG; polyethyleneglycol; PipAc; 2-(piperazin-1-yl)acetic acid; CNS; central nervous system; DIO; diet-induced obesity; EMCS; N-(6-maleimidocaproyloxy)succinimide;
A randomized, three-period crossover study of umeclidinium as monotherapy in adult patients with asthma
Keywords: زمان به حداکثر غلظت پلاسما; Asthma; Fixed-dose combination; Muscarinic antagonist; Inhaled corticosteroid; Trough FEV1; Ae; amount of dose excreted unchanged in urine; AE; adverse event; ALT; alanine aminotransferase; AUC; area under the curve; BID; twice daily; bpm; beats per minut
Preclinical pharmacokinetic and toxicological evaluation of MIF-1 peptidomimetic, PAOPA: Examining the pharmacology of a selective dopamine D2 receptor allosteric modulator for the treatment of schizophrenia
Keywords: زمان به حداکثر غلظت پلاسما; 5-HT2; 5-hydroxytryptamine; 6-OHDA; 6-hydroxydopamine; AM; allosteric modulator; AUC; area under curve; AUCINF; area under curve extrapolated to infinity; AUClast; area under curve from dosing to observation; AUMC; area under first moment curve; CL; total
Human disposition of L-theanine in tea or aqueous solution
Keywords: زمان به حداکثر غلظت پلاسما; AUC700ââ; area under the plasma concentration-time curve from t = 0 to â min corrected to a body weight of 70 kg; BW; body weight; Cp; plasma concentration; Cmax,70; maximum plasma concentration corrected to a body weight of 70 kg; Cl/Fabs; cl